These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18840863)

  • 21. Legal features of the drug advertising.
    Pashkov VM; Olefir AA; Bytyak OY
    Wiad Lek; 2017; 70(1):133-138. PubMed ID: 28343208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The regulation of medical visits: necessary but insufficient].
    Madridejos Mora R
    Aten Primaria; 2003 Dec; 32(10):562-3. PubMed ID: 14697178
    [No Abstract]   [Full Text] [Related]  

  • 23. "Bonne Année", "Gutes Neues Jahr"? Will 2007 be a "Happy New Year" for children's medicines in Europe?
    Stephenson T
    Arch Dis Child; 2007 Aug; 92(8):661-3. PubMed ID: 17642477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EU health ministers reject proposal for limited direct to consumer advertising.
    Watson R
    BMJ; 2003 Jun; 326(7402):1284. PubMed ID: 12805139
    [No Abstract]   [Full Text] [Related]  

  • 25. Self-Regulation in the Pharmaceutical Industry: The Exposure of Children and Adolescents to Erectile Dysfunction Commercials.
    Arnold DG; Oakley JL
    J Health Polit Policy Law; 2019 Oct; 44(5):765-787. PubMed ID: 31199865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complaints addressed by regulatory authorities in drug advertising targeted at consumers: Cases across three, different countries.
    Song SY; Lee JH; Kim SC; Choi JW; Bae J; Kim E
    Res Social Adm Pharm; 2019 Oct; 15(10):1274-1279. PubMed ID: 30552049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimenting with direct-to-consumer advertising.
    Lancet; 2000 Aug; 356(9230):607. PubMed ID: 10968426
    [No Abstract]   [Full Text] [Related]  

  • 28. A critique of emerging European legislation in the pharmaceutical industry: a clinical trials analysis.
    Murray E; McAdam R; Burke MT
    Int J Health Care Qual Assur Inc Leadersh Health Serv; 2004; 17(7):389-93. PubMed ID: 15552394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718
    [No Abstract]   [Full Text] [Related]  

  • 30. Reorienting the course of medicines policy: actions are bearing fruit.
    Prescrire Int; 2003 Oct; 12(67):192-4. PubMed ID: 14619908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efforts to ban direct-to-consumer advertising in New Zealand: a call to action.
    Hoffman JR; Cooper RJ
    Br J Gen Pract; 2003 Apr; 53(489):267-9. PubMed ID: 12879824
    [No Abstract]   [Full Text] [Related]  

  • 32. Disclosing Prescription-Drug Prices in Advertisements - Legal and Public Health Issues.
    Dusetzina SB; Mello MM
    N Engl J Med; 2018 Dec; 379(24):2290-2293. PubMed ID: 30428275
    [No Abstract]   [Full Text] [Related]  

  • 33. European Commission's proposals on trade secrets.
    McKee M; Labonté R
    BMJ; 2015 Mar; 350():h1369. PubMed ID: 25762539
    [No Abstract]   [Full Text] [Related]  

  • 34. Direct-to-consumer advertising: the European Commission's plan.
    Prescrire Int; 2010 Jun; 19(107):142. PubMed ID: 20738053
    [No Abstract]   [Full Text] [Related]  

  • 35. Can a medical need clause help manage the growing costs of prescription drugs in the EU?
    Brooks E; Geyer R
    Health Econ Policy Law; 2016 Apr; 11(2):179-92. PubMed ID: 26333920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Better medicines for children: the European Paediatric Initiative is five years old].
    Morales-Olivas FJ
    An Pediatr (Barc); 2014 Mar; 80(3):135-7. PubMed ID: 24507821
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmaceuticals. Adopt an orphan.
    Karr A
    Health Serv J; 1999 Nov; 109(5681):28. PubMed ID: 10724720
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical research. Effects of European legislation and current developments].
    Sudhop T; Enzmann H; Klar R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Apr; 52(4):375-6. PubMed ID: 19343281
    [No Abstract]   [Full Text] [Related]  

  • 39. Regulatory Consequences of "Brexit" for the Development of Medicinal Products.
    Jackson EL; Feldschreiber P; Breckenridge A
    Clin Pharmacol Ther; 2017 Aug; 102(2):183-184. PubMed ID: 28555841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EU should strengthen protection against fake drugs, UK report says.
    Mayor S
    BMJ; 2006 Nov; 333(7578):1090. PubMed ID: 17124217
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.